相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibition of PI3K by PX-866 Prevents Transforming Growth Factor-α-Induced Pulmonary Fibrosis
Timothy D. Le Cras et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
LW6, a novel HIF-1 inhibitor, promotes proteasomal degradation of HIF-1α via upregulation of VHL in a colon cancer cell line
Kyeong Lee et al.
BIOCHEMICAL PHARMACOLOGY (2010)
A novel steroidal inhibitor of estrogen-related receptor α (ERRα)
Sarah J. Duellman et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Development of novel inhibitors targeting HIF-1α towards anticancer drug discovery
Nilambari Yewalkar et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Boron-containing phenoxyacetanilide derivatives as hypoxia-inducible factor (HIF)-1α inhibitors
Kazuki Shimizu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
FM19G11 A new modulator of hif that links mTOR activation with the DNA damage checkpoint pathways
Francisco Javier Rodriguez-Jimenez et al.
CELL CYCLE (2010)
Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of the Combination of Sorafenib and Tanespimycin
Ulka N. Vaishampayan et al.
CLINICAL CANCER RESEARCH (2010)
Prolyl hydroxylase domain-containing protein inhibitors as stabilizers of hypoxia-inducible factor: small molecule-based therapeutics for anemia
Lin Yan et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2010)
FM19G11, a New Hypoxia-inducible Factor (HIF) Modulator, Affects Stem Cell Differentiation Status
Victoria Moreno-Manzano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Neratinib, an Irreversible Pan-ErbB Receptor Tyrosine Kinase Inhibitor: Results of a Phase II Trial in Patients With Advanced Non-Small-Cell Lung Cancer
Lecia V. Sequist et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Identification of HSP60 as a Primary Target of o-Carboranylphenoxyacetanilide, an HIF-1α Inhibitor
Hyun Seung Ban et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
A novel benzimidazole analogue inhibits the hypoxia-inducible factor (HIF)-1 pathway
Mi-Sun Won et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
The selective hypoxia inducible factor-1 inhibitor PX-478 provides in vivo radiosensitization through tumor stromal effects
David L. Schwartz et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Targeting the phosphoinositide 3-kinase pathway in cancer
Pixu Liu et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
A RNA antagonist of hypoxia-inducible factor-1α, EZN-2968, inhibits tumor cell growth
Lee M. Greenberger et al.
MOLECULAR CANCER THERAPEUTICS (2008)
HYPOXIA AND METABOLISM SERIES - TIMELINE The impact of O2 availability on human cancer
Jessica A. Bertout et al.
NATURE REVIEWS CANCER (2008)
(Aryloxyacetylamino)benzoic acid analogues: A new class of hypoxia-inducible factor-1 inhibitors
Kyeong Lee et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
A phase I pharmacokinetic and pharmacodynamic study of PX-12, a novel inhibitor of thioredoxin-1, in patients with advanced solid tumors
Ramesh K. Ramanathan et al.
CLINICAL CANCER RESEARCH (2007)
Chaetocin: a promising new antimyeloma agent with in vitro and in vivo activity mediated via imposition of oxidative stress
Crescent R. Isham et al.
BLOOD (2007)
Cell type-specific, topoisomerase II-dependent inhibition of hypoxia-inducible factor-1α protein accumulation by NSC 644221
Mark Creighton-Gutteridge et al.
CLINICAL CANCER RESEARCH (2007)
RACK1 competes with HSP90 for binding to HIF-1α and is required for O2-independent and HSP90 inhibitor-induced degradation of HIF-1α
Ye V. Liu et al.
MOLECULAR CELL (2007)
Opinion - Angiogenesis: an organizing principle for drug discovery?
Judah Folkman
NATURE REVIEWS DRUG DISCOVERY (2007)
A phase II trial of 17-(Allylamino)-17-demethoxygeldanamycin in patients with papillary and clear cell renal cell carcinoma
Ellen A. Ronnen et al.
INVESTIGATIONAL NEW DRUGS (2006)
Hypoxia signalling in cancer and approaches to enforce tumour regression
Jacques Pouyssegur et al.
NATURE (2006)
Angiogenesis inhibitors derived from thalidomide
T Noguchi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Targeting hypoxia and angiogenesis through HIF-1α inhibition
JA Diaz-Gonzalez et al.
CANCER BIOLOGY & THERAPY (2005)
Antiangiogenic properties of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin: An orally bioavailable heat shock protein 90 modulator
G Kaur et al.
CLINICAL CANCER RESEARCH (2004)
Human ACAT-1 and -2 inhibitory activities of saucerneol B, manassantin A and B isolated from Saururus chinensis
WS Lee et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Suppression of RelA/p65 transactivation activity by a lignoid manassantin isolated from Saururus chinensis
JH Lee et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Lignans from Saururus chinensis inhibiting the transcription factor NF-κB
BY Hwang et al.
PHYTOCHEMISTRY (2003)
A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors
A Kamal et al.
NATURE (2003)
Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1α-degradative pathway
JS Isaacs et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Cellular adaptation to hypoxia:: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression
RH Wenger
FASEB JOURNAL (2002)
HIF-1α binding to VHL is regulated by stimulus-sensitive proline hydroxylation
F Yu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
HIFα targeted for VHL-mediated destruction by proline hydroxylation:: Implications for O2 sensing
M Ivan et al.
SCIENCE (2001)
Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation
P Jaakkola et al.
SCIENCE (2001)
Inhibitory effect of YC-1 on the hypoxic induction of erythropoietin and vascular endothelial growth factor in Hep3B cells
YS Chun et al.
BIOCHEMICAL PHARMACOLOGY (2001)
HIF-1-dependent transcriptional activity is required for oxygen-mediated HIF-1α degradation
E Berra et al.
FEBS LETTERS (2001)
Natural product-like combinatorial libraries based on privileged structures. 1. General principles and solid-phase synthesis of benzopyrans
KC Nicolaou et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2000)
Natural product-like combinatorial libraries based on privileged structures. 2. Construction of a 10 000-membered benzopyran library by directed split-and-pool chemistry using NanoKans and optical encoding
KC Nicolaou et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2000)
Natural product-like combinatorial libraries based on privileged structures. 3. The libraries from libraries principle for diversity enhancement of benzopyran libraries
KC Nicolaou et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2000)
Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein
ME Cockman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel-Lindau protein
M Ohh et al.
NATURE CELL BIOLOGY (2000)
分享论文
